Stake Purchase • Life Science

Sonic Healthcare Invests In Microba Life Sciences

On November 28, 2022, Sonic Healthcare invested in life science company Microba Life Sciences

Investment Context
  • This is Sonic Healthcare’s 3rd transaction in the Life Science sector.
  • This is Sonic Healthcare’s 11th transaction in Australia.

Explore All 282 Stake Purchase Life Science Deals - Search the Database Free


Investment Summary

Date November 28, 2022
Target Microba Life Sciences
Sector Life Science
Investor(s) Sonic Healthcare
Deal Type Stake Purchase

Target Company

Microba Life Sciences

Brisbane City, Australia
Microba Life Sciences is a microbiome company development of novel therapeutics for major chronic diseases and delivering gut microbiome testing services globally to researchers, clinicians, and consumers. Microba Life Sciences was founded in 2018 and is based in Brisbane City, Australia.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Sonic Healthcare

Sydney, Australia

Category Company
Founded 1934
Sector Medical Products
Employees37,000
Revenue 8.9B AUD (2024)
DESCRIPTION

Sonic Healthcare is a medical diagnostics companies, providing laboratory and radiology services to medical practitioners, hospitals, community health services, and their collective patients. Sonic Healthcare was founded in 1934 and is based in Sydney, Australia.


Deal Context for Investor #
Overall 39 of 43
Sector: Life Science 3 of 6
Type: Stake Purchase 3 of 3
Country: Australia 11 of 11
Year: 2022 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-12-17 ProPath

Dallas, Texas, United States

ProPath is a medically led anatomical pathology (AP) company. ProPath was founded in 1966 and is based in Dallas, Texas.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2023-04-03 Diagnosticum

Budapest, Hungary

Diagnosticum is a clinical and anatomical pathology laboratory groups operating in the South East of Germany, around the city of Dresden.

Buy €190M